Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07409025

Sensory Stimulation as a Driver of Diet-induced Thermogenesis

This study aims to assess the influence of sensory stimulation on diet-induced energy expenditure by way of a clinical cross-over trial in 24 healthy participants either receiving a meal bolus with (orally) and without sensory stimulation (nasogastric-tube).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Basel, Department of Endocrinology

Basel, 4031, Switzerland

Location status: Recruiting

Location contact

Matthias Betz, Prof.

CONTACT

[email protected]

0041 61 556 56 54

About this study

Here, the investigators postulate sensory stimulation (i.e. the sight, smell, auditory and tactile properties, as well as the taste of food) to be drivers of diet induced thermogenesis, an insufficiently understood mechanism of body weight regulation. Research into this area to date has focused on macro-nutrient composition delivered unphysiologically (i.v. or in form of unpalatable solutions). Thereby neglecting the bulk of food-intake associated sensory stimulation and thus the contribution of the brain itself.

The investigators aim to gain insight into the role of sensory stimulation in this context by means of a cross-over proof-of concept exploratory clinical trial. Comparing 24 healthy human volunteers receiving a meal bolus with (orally) and without sensory stimulation (nasogastric-tube) by indirect calorimetry, tissue-adjacent temperature measurements and ex vivo analyses.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy volunteers of any gender
  • BMI between 18-25 kg/m2
  • age between 18 and 40 years

Exclusion criteria

  • concomitant medication except for prescription free analgetics (paracetamol, NSAIDs) and oral contraceptives
  • clinically significant concomitant disease states (e.g. renal failure, hepatic dysfunction, cardiovascular disease, diabetes mellitus),
  • allergy to local anaesthetic or any of the study meal ingredients
  • known or suspected non-compliance, drug or alcohol abuse
  • smoker / habitual tobacco use
  • habitual excessive alcohol consumption
  • inability to follow the procedures of the study
  • participation in another study with investigational drug within the 30 days preceding and during the present study
  • previous enrolment into the current study
  • enrolment of the investigator, his/her family members, employees and other dependent persons
  • uncontrolled hypo- or hyperthyroidism
  • pregnancy or lactation

Treatment and study plan

sensory exposure

Procedure

Administration of a full meal orally ("regular eating") in study visit A

sensory deprivation

Procedure

Administration of a full meal via nasogastric tube in study visit B (thereby masking it from the senses)

Primary outcomes

  1. Diet-induced energy expenditure

    Time frame: data will be collected from baseline (30 minutes before meal bolus administration) up to 300 minutes post-administration, divided into five segments: four 30-minute intervals and one 75-minute interval.

    diet-induced thermogenesis as determined by indirect calorimetry measurements of VO2 in the sensory exposure condition (full meal) as compared to the sensory deprivation condition (same meal via nasogastric tube)

Secondary outcomes

  1. Skin temperature

    Time frame: data will be collected from baseline (60 minutes before meal bolus administration) up to 300 minutes post-administration

    brown adipose tissue activity as measured by supraclavicular skin temperature in response to both trial conditions It will be measured using wireless temperature sensors (iButton Thermochron) attached to the skin at 11 pre-defined locations

Study contacts

Contact information is provided by the study sponsor or research team.

Matthias Betz, Prof.

CONTACT

[email protected]

0041 61 556 56 54

Sophia J Wiedemann, Dr. phil. Dr. med. M.Sc.

CONTACT

[email protected]

0041 61 328 44 97

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Official study title

SEnsory stimulatioN aS A Driver of dieT-induced Thermogenesis - the SENSATION Trial

Acronym: SENSATION

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Feb 13, 2026
Registry last updated
Jul 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.